Cited by 276Diabetes, Cardiovascular Risks, and LipoproteinsAcute Myocardial Infarction ResearchHealthcare Systems and Public Health

The DOI matches its Crossref record, with a small difference in title or year; 39 of the 40 references it cites were found in a registry or an index.

Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction

Lee, Chong Do, Folsom, Aaron R., Pankow, James S., Brancati, Frederick L.·2004·Circulation

DOI 10.1161/01.cir.0000116389.61864.de

Open this paper in CoChat — free account

Abstract

Background— Whether diabetic patients without a history of myocardial infarction (MI) have the same risk of coronary heart disease (CHD) events as nondiabetic patients with a history of MI remains controversial. We compared risks of CHD and stroke events and mortality from cardiovascular disease (CVD) in diabetic and nondiabetic men and women with and without a history of MI. Methods and Results— We followed a total of 13 790 African American and white men and women ages 45 to 64 years who participated in the Atherosclerosis Risk in Communities study, beginning in 1987 to 1989. There were 634 fatal CHD or nonfatal MI events, 312 fatal or nonfatal strokes, and 358 deaths from CVD during an average of 9 years of follow-up (125 998 person-years). After adjustment for age, sex, race, Atherosclerosis Risk in Communities field center, and multiple baseline risk factors, patients who had a history of MI without diabetes at baseline had 1.9 times the risk of fatal CHD or nonfatal MI (95% CI, 1.35 to 2.56; P <0.001) compared with diabetic patients without a prior history of MI. The nondiabetic patients with MI also had 1.8 times the risk of CVD mortality compared with diabetic patients without MI (95% CI, 1.22 to 2.72; P =0.003). However, stroke risk was similar between diabetic patients without MI and nondiabetic patients with MI (RR, 1.05; 95% CI, 0.61 to 1.79; P =0.87). We also observed that nondiabetic patients with MI had a carotid artery wall thickness similar to diabetic patients without MI ( P =0.77). Conclusions— Diabetic patients without MI had lower risk of CHD events and mortality from CVD compared with nondiabetic patients with MI, but stroke risk was similar between these 2 groups.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000116389.61864.de

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J. A. H., BUREMA, J., & Frijters, J. E. R. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,950
THE ATHEROSCLEROSIS RISK IN COMMUNIT (ARIC) STUDY: DESIGN AND OBJECTIVES
THE ARIC INVESTIGATORS (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115184 · Cited by 3,510

Show all 40 references

Research works printed but not linked: 8

10.1161/circ.100.10.1134 · DOI
10.1161/circ.97.18.1837 · DOI
10.1001/jama.1988.03410230074031 · DOI
Geiss LS Herman WH Smith PJ. Mortality in non-insulin-dependent diabetes. In: National Diabetes Data Group ed. Diabetes in America. Bethesda Md: US Department of Health and Human Services Public Health Service National Institutes of Health; 1995: 233–257.
1982, Clin Chem, 28, 1574.
10.1161/str.30.4.736 · DOI
10.1161/circ.102.9.1014 · DOI
10.1161/atv91.12.6.1591228 · DOI

Sorted by citations

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Diabetes Care · doi:10.2337/dc07-9917 · Cited by 1,055
Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study
Booth, G. L., Kapral, M. K., Fung, K., & Tu, J. V. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68967-8 · Cited by 782
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R. H., Fonseca, V. A., Gerstein, H. C., Grundy, S. M., Nesto, R. W., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.179294 · Cited by 634
Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes
Knopp, R. H., d’Emden, M., Smilde, J. G., Pocock, S. J., & on behalf of the ASPEN Study Group (2006) · Diabetes Care · doi:10.2337/dc05-2415 · Cited by 550
Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk
Schramm, T. K., Gislason, G., Køber, L., Rasmussen, S., Rasmussen, J. N., Abildstrom, S. Z., Hansen, M. L., Folke, F., Buch, P., Madsen, M. M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.720847 · Cited by 540
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Cardiovascular risk in diabetes mellitus: Epidemiology, assessment and prevention
Wong, N. D., & Sattar, N. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00877-z · Cited by 495
Type 2 Diabetes as a “Coronary Heart Disease Equivalent”
Juutilainen, A., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2901 · Cited by 452
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
De Berardis, G., Sacco, M., Strippoli, G. F. M., Pellegrini, F., Graziano, G., Tognoni, G., & Nicolucci, A. (2009) · BMJ · doi:10.1136/bmj.b4531 · Cited by 395
Is diabetes a coronary risk equivalent? Systematic review and meta‐analysis
Bulugahapitiya, U., Siyambalapitiya, S., Sithole, J., & IDRIS, I. R. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02640.x · Cited by 377
The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus
Ginsberg, H. N., & MacCallum, P. R. (2009) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00044.x · Cited by 331
Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study
Marrugat, J., Subirana, I., Comín, E., Cabezas, C., Vila, J., Elosúa, R., Nam, B., Ramos, R., Sala, J., Solanas, P., et al. (2006) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2005.038505 · Cited by 324
Diabetes in heart failure: prevalence and impact on outcome in the population
From, A. M., Leibson, C. L., Bursi, F., Redfield, M. M., Weston, S. A., Jacobsen, S. J., Rodeheffer, R. J., & Roger, V. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.05.024 · Cited by 295
Diabetes and Coronary Revascularization
Flaherty, J. D. (2005) · JAMA · doi:10.1001/jama.293.12.1501 · Cited by 272
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies
Loke, Y. K., Kwok, C. S., & Singh, S. (2011) · BMJ · doi:10.1136/bmj.d1309 · Cited by 247
Epidemiology of Coronary Artery Disease
Duggan, J. P., Peters, A. S., Trachiotis, G. D., & Antevil, J. L. (2022) · Surgical Clinics of North America · doi:10.1016/j.suc.2022.01.007 · Cited by 266
Association of Major and Minor ECG Abnormalities With Coronary Heart Disease Events
Bauer, D. C. (2012) · JAMA · doi:10.1001/jama.2012.434 · Cited by 213
Complications of the Type 2 Diabetes Mellitus
Farmaki, P., Damaskos, C., Garmpis, N., Garmpi, A., Savvanis, S., & Diamantis, E. (2021) · Current Cardiology Reviews · doi:10.2174/1573403x1604201229115531 · Cited by 191
A Community-Based Study of Stroke Incidence after Myocardial Infarction
Witt, B. J., Brown, R. D., Jacobsen, S. J., Weston, S. A., Yawn, B. P., & Roger, V. L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-11-200512060-00006 · Cited by 177
Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction
Hu, G., Jousilahti, P., Qiao, Q., Katoh, S., & Tuomilehto, J. (2005) · Diabetologia · doi:10.1007/s00125-005-1730-6 · Cited by 176
Assessing the cardio–cerebrovascular safety of vildagliptin: meta‐analysis of adjudicated events from a large Phase III type 2 diabetes population
Schweizer, A., Dejager, S., Foley, J. E., Couturier, A., Ligueros‐Saylan, M., & Kothny, W. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01215.x · Cited by 162
Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women
Avogaro, A., Giorda, C. B., Maggini, M., Mannucci, E., Raschetti, R., Lombardo, F. L., Alegiani, S. S., Turco, S., Velussi, M., & Ferrannini, E. (2007) · Diabetes Care · doi:10.2337/dc06-2558 · Cited by 169
AHA/ACCF 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults
Redberg, R. F., Benjamin, E. J., Bittner, V., Braun, L. T., Goff, D. C., Havas, S., Labarthe, D. R., Limacher, M. C., Lloyd‐Jones, D. M., Mora, S., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192617 · Cited by 157
Mitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic Cardiomyopathy
Ni, R., Zheng, D., Xiong, S., Hill, D. J., Sun, T., Gardiner, R. B., Fan, G., Lu, Y., Abel, E. D., Greer, P. A., et al. (2015) · Diabetes · doi:10.2337/db15-0963 · Cited by 145
Elevated Serum Uric Acid Concentrations Independently Predict Cardiovascular Mortality in Type 2 Diabetic Patients
Zoppini, G., Targher, G., Negri, C., Stoico, V., Perrone, F., Muggeo, M., & Bonora, E. (2009) · Diabetes Care · doi:10.2337/dc09-0625 · Cited by 142
Reduced Expression of ATP-Binding Cassette Transporter G1 Increases Cholesterol Accumulation in Macrophages of Patients With Type 2 Diabetes Mellitus
Mauldin, J., Nagelin, M. H., Wojcik, A. J., Srinivasan, S. R., Skaflen, M. D., Ayers, C. R., McNamara, C. A., & Hedrick, C. C. (2008) · Circulation · doi:10.1161/circulationaha.107.741314 · Cited by 134
Inclusion of Stroke in Cardiovascular Risk Prediction Instruments
Lackland, D. T., Elkind, M. S. V., D’Agostino, R. B., Dhamoon, M. S., Goff, D. C., Higashida, R. T., McClure, L. A., Mitchell, P. H., Sacco, R. L., Sila, C. A., et al. (2012) · Stroke · doi:10.1161/str.0b013e31825bcdac · Cited by 136
Framingham Risk Score and Alternatives for Prediction of Coronary Heart Disease in Older Adults
Rodondi, N., Locatelli, I., Aujesky, D., Butler, J., Vittinghoff, E., Simonsick, E. M., Satterfield, S., Newman, A. B., Wilson, P. W. F., Pletcher, M. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034287 · Cited by 123
Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes
Severson, D. L. (2004) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-065 · Cited by 111
ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults
Redberg, R. F., Benjamin, E. J., Bittner, V., Braun, L. T., Goff, D. C., Havas, S., Labarthe, D. R., Limacher, M. C., Lloyd‐Jones, D. M., Mora, S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.005 · Cited by 110
Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community
Siscovick, D. S., Sotoodehnia, N., Rea, T. D., Raghunathan, T. E., Jouven, X., & Lemaître, R. N. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9133-5 · Cited by 106
Markers of Atherosclerosis and Inflammation for Prediction of Coronary Heart Disease in Older Adults
Rodondi, N., Marques-Vidal, P. M., Butler, J., Sutton-Tyrrell, K., Cornuz, J., Satterfield, S., Harris, T. B., Bauer, D. C., Ferrucci, L., Vittinghoff, E., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwp428 · Cited by 104
Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia–reperfusion injury
Chinda, K., Palee, S., Surinkaew, S., Phimphilai, M., Chattipakorn, S. C., & Chattipakorn, N. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.011 · Cited by 103
Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel
Shepherd, J., Betteridge, J. D., Gaal, L. V., & Panel, O. B. O. A. E. C. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x43677 · Cited by 100
Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus
Worm, S. W., Wit, S. D., Weber, R. K., Sabin, C. A., Reiss, P., El‐Sadr, W., Monforte, A. D., Kirk, O., Fontas, É., Dabis, F., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.790857 · Cited by 99
Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes
Sibal, L., Sibal, L., Agarwal, & Home, P. (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s8540 · Cited by 95
The Metabolic Score for Insulin Resistance (METS-IR) as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study among Korean without Diabetes
Yoon, J., Jung, D., Lee, Y., & Park, B. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080742 · Cited by 100
The Potential of Myocardial Perfusion Scintigraphy for Risk Stratification of Asymptomatic Patients With Type 2 Diabetes
Bax, J. J., Bonow, R. O., Tschöpe, D., Inzucchi, S. E., & Barrett, E. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.077 · Cited by 88
Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)
Krempf, M., Parhofer, K. G., Steg, P. G., Bhatt, D. L., Ohman, E. M., Röther, J., Goto, S., Pasquet, B., & Wilson, P. W. F. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.10.048 · Cited by 82
The triglyceride-glucose index predicts ischemic heart disease risk in Koreans: a prospective study using National Health Insurance Service data
Park, B., Lee, Y., Lee, H. S., & Jung, D. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01186-2 · Cited by 82
Diabetes and Coronary Heart Disease as Risk Factors for Mortality in Older Adults
Carnethon, M. R., Biggs, M. L., Barzilay, J., Kuller, L. H., Mozaffarian, D., Mukamal, K., Smith, N. L., & Siscovick, D. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.11.023 · Cited by 77
The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease.
Hu, G., Jousilahti, P., Qiao, Q., Peltonen, M., Katoh, S., & Tuomilehto, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.039 · Cited by 75
Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus
Djaberi, R., Beishuizen, E. D., Pereira, A. M., Rabelink, T. J., Smit, J. W. A., Tamsma, J. T., Huisman, M. V., & Jukema, J. W. (2008) · Diabetologia · doi:10.1007/s00125-008-1062-4 · Cited by 73
Cardiovascular Disease and Diabetic Kidney Disease
Maqbool, M., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.02.003 · Cited by 73
Influence of diabetes and bilateral internal thoracic artery grafts on long-term outcome for multivessel coronary artery bypass grafting☆
Stevens, L., Carrier, M., Perrault, L. P., Hébert, Y., Cartier, R., Bouchard, D., Fortier, A., & Pellerin, M. (2004) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2004.10.048 · Cited by 69
Diabetes mellitus and risk of fatal ischaemic heart disease by gender: 18 years follow-up of 74 914 individuals in the HUNT 1 Study
Dale, A. C., Nilsen, T. I. L., Vatten, L. J., Midthjell, K., & Wiseth, R. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm447 · Cited by 67
Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study
Buyken, A. E., von Eckardstein, A., Schulte, H., Cullen, P., & Assmann, G. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3280142037 · Cited by 72
AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions
Nicolucci, A., Berardis, G. D., Sacco, M., & Tognoni, G. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm248 · Cited by 67
Nocturnal Blood Pressure Elevation Predicts Progression of Albuminuria in Elderly People With Type 2 Diabetes
Palmas, W., Pickering, T. G., Teresi, J. A., Schwartz, J. E., Eguchi, K., Field, L., Weinstock, R. S., & Shea, S. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.07170.x · Cited by 67
Adiponectin increases macrophages cholesterol efflux and suppresses foam cell formation in patients with type 2 diabetes mellitus
Wang, M., Wang, D., Zhang, Y., Wang, X., Liu, Y., & Xia, M. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.017 · Cited by 66
The Effect of Survival Bias on Case-Control Genetic Association Studies of Highly Lethal Diseases
Anderson, C. D., Nalls, M. A., Biffi, A., Rost, N. S., Greenberg, S. M., Singleton, A., Meschia, J. F., & Rosand, J. M. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.957928 · Cited by 66
Insulin resistance, diabetes and cardiovascular risk: approaches to treatment
Rosenberg, D. E., Jabbour, S. A., & Goldstein, B. J. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00446.x · Cited by 65
Funciones de riesgo en la prevención primaria de las enfermedades cardiovasculares
Grau, M., & Marrugat, J. (2008) · Revista Española de Cardiología · doi:10.1157/13117732 · Cited by 60
A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design
Preiss, D., Sattar, N. A., & McMurray, J. J. V. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.10.019 · Cited by 60
Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study
Pajunen, P., Koukkunen, H., Ketonen, M., Jerkkola, T., Immonen‐Räihä, P., Kärjä-Koskenkari, P., Kuulasmaa, K., Palomäki, P., Mustonen, J. N., Lehtonen, A., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-0019-0 · Cited by 58
Predictive Value of the Atherogenic Index of Plasma (AIP) for the Risk of Incident Ischemic Heart Disease among Non-Diabetic Koreans
Kim, J. J., Yoon, J., Lee, Y., Park, B., & Jung, D. (2021) · Nutrients · doi:10.3390/nu13093231 · Cited by 58
Development and Validation of the Economic Assessment of Glycemic Control and Long-Term Effects of Diabetes (EAGLE) Model
Mueller, E., Maxion‐Bergemann, S., Gultyaev, D., Walzer, S., Freemantle, N., Mathieu, C., Bolinder, B., Gerber, R. A., Kvasz, M., & Bergemann, R. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.219 · Cited by 55
Pathophysiology of diabetic dyslipidemia:implications for atherogenesis and treatment
Sugden, M., & Holness, M. (2011) · Clinical Lipidology · doi:10.2217/clp.11.32 · Cited by 55
Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction
Schmitt, V. H., Hobohm, L., Münzel, T. F., Wenzel, P., Gori, T., & Keller, K. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.11.003 · Cited by 59
The connection between hypertension and diabetes and their role in heart and kidney disease development
Hezam, A. A. M., Shaghdar, H. B. M., & Chen, L. (2024) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_470_23 · Cited by 65
Duration-dependent impact of cardiometabolic diseases and multimorbidity on all-cause and cause-specific mortality: a prospective cohort study of 0.5 million participants
Han, Y., Hu, Y., Yu, C., Sun, D., Pang, Y., Pei, P., Yang, L., Chen, Y., Du, H., Liu, J., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01858-9 · Cited by 52
Patients with diabetes without significant angiographic coronary artery disease have the same risk of myocardial infarction as patients without diabetes in a real-world population receiving appropriate prophylactic treatment
Olesen, K. K. W., Madsen, M., Egholm, G., Thim, T., Jensen, L. O., Raungaard, B., Bøtker, H. E., Sørensen, H. T., & Maeng, M. (2017) · Diabetes Care · doi:10.2337/dc16-2388 · Cited by 51
Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH Registry
Dallongeville, J., Bhatt, D. L., Steg, P. G., Ravaud, P., Wilson, P. W. F., Eagle, K. A., Goto, S., Mas, J., Montalescot, G., & (for the REACH Registry Investigators) (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826710394305 · Cited by 49
Inflammation, Atherosclerosis, and Aspects of Insulin Action
Bloomgarden, Z. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2312 · Cited by 48
Treatment Goals in Diabetes
Melmer, A., & Laimer, M. W. (2016) · Endocrine development · doi:10.1159/000439364 · Cited by 53
Rendimiento de la estimación del riesgo cardiovascular en España mediante la utilización de distintas funciones
Comín, E., Solanas, P., Cabezas, C., Subirana, I., Ramos, R., Badía, J. G., Cordón, F., Grau, M., Vila, J., & Marrugat, J. (2007) · Revista Española de Cardiología · doi:10.1157/13108274 · Cited by 48
New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population
Hadaegh, F., Fahimfar, N., Khalili, D., Sheikholeslami, F. H., & Azizi, F. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-84 · Cited by 47
Lipid control in patients with diabetes mellitus
Betteridge, D. J. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.23 · Cited by 48
Long-Term Cardiovascular Risk in Type 2 Diabetic Compared With Nondiabetic First Acute Myocardial Infarction Patients
Cano, J. F., Baena-Díez, J. M., Franch‐Nadal, J., Vila, J., Tello, S., Sala, J., Elosúa, R., Marrugat, J., & on behalf of the REGICOR and GEDAPS Investigators (2010) · Diabetes Care · doi:10.2337/dc10-0560 · Cited by 46
A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Filling the Gaps
López-Jiménez, F. A., Simha, V., Thomas, R. J., Allison, T. G., Basu, A., Fernandes, R., Hurst, R. T., Kopecky, S. L., Kullo, I. J., Mulvagh, S. L., et al. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.06.016 · Cited by 45
Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study
Lundby‐Christensen, L., Almdal, T., Carstensen, B., Tarnow, L., & Wiinberg, N. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-40 · Cited by 44
Low incidence of cardiovascular events in Japanese patients with Type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20): Cardiovascular outcomes in Japanese Type 2 diabetes
Yokoyama, H., Matsushima, M., Kawai, K., Hirao, K., Oishi, M., Sugimoto, H., Takeda, H., Minami, M., Kobayashi, M., Sone, H., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03347.x · Cited by 41
Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS)
Mondesir, F. L., Brown, T. M., Muntner, P., Durant, R. W., Carson, A. P., Safford, M. M., & Levitan, E. B. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.08.002 · Cited by 42
Triglyceride to HDL-Cholesterol Ratio and the Incident Risk of Ischemic Heart Disease Among Koreans Without Diabetes: A Longitudinal Study Using National Health Insurance Data
Park, B., Jung, D., Lee, H. S., & Lee, Y. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.716698 · Cited by 44
NHG-Standaard Cardiovasculair risicomanagement
Wiersma, T., Boukes, F., Geijer, R. M. M., & Goudswaard, A. N. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6614-9_6 · Cited by 40
The effect of diabetes and stroke at baseline and during follow-up on stroke mortality
Hu, G., Jousilahti, P., Sarti, C., Antikaínen, R., & Tuomilehto, J. O. (2006) · Diabetologia · doi:10.1007/s00125-006-0378-1 · Cited by 40
Diabetes and coronary artery disease impose similar cardiovascular morbidity and mortality on renal transplant candidates
Gowdak, L. H. W., de Paula, F. J., César, L. A. M., Filho, E. E. M., Ianhez, L. E., Krieger, E. M., Ramires, J. A. F., & Lima, J. J. G. D. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl781 · Cited by 39
Diabetes in Mice with Monogenic Obesity: The db/db Mouse and Its Use in the Study of Cardiac Consequences
Belke, D. D., & Severson, D. L. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-068-7_4 · Cited by 38
Diabetes, Myocardial Infarction and Stroke Are Distinct and Duration-Dependent Predictors of Subsequent Cardiovascular Events and All-Cause Mortality in Older Men
Yeap, B. B., McCaul, K. A., Flicker, L. A., Hankey, G. J., Almeida, O. P., Golledge, J., & Norman, P. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3339 · Cited by 37
Metformin ameliorates Ox-LDL-induced foam cell formation in raw264.7 cells by promoting ABCG-1 mediated cholesterol efflux
He, X. M., Chen, X., Wang, L., Wang, W., Liang, Q., Yi, L., Wang, Y., & Gao, Q. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.09.024 · Cited by 37
Is type 2 diabetes really a coronary heart disease risk equivalent?
Saely, C. H., & Drexel, H. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2013.05.003 · Cited by 34
Favourable trends in the incidence and outcome of myocardial infarction in nondiabetic, but not in diabetic, subjects: findings from the MONICA myocardial infarction registry in northern Sweden in 1989–2000
Rautio, A., Lundberg, V., Messner, T., Nasic, S., Stegmayr, B. G., & Eliasson, M. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01552.x · Cited by 36
Cardiovascular disease risk in subjects with type 2 diabetes mellitus in a population in southern Spain
Rallo, B. L., Blanco-Gonzalez, M., Casas-Ciria, I., Marín-Andrade, J. A., Mendez-Segovia, J. C., Moratalla, G., Quintero-Dominguez, R., Ramirez-Raya, M., Guerrero-Pinedo, M. J., & Aguilar‐Diosdado, M. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.09.028 · Cited by 33
Interplay of diabetes and coronary heart disease on cardiovascular mortality: Table 1
Boccara, F., & Cohen, A. A. (2004) · Heart · doi:10.1136/hrt.2004.035766 · Cited by 34
Diabetes and Cardiovascular Disease
Bloomgarden, Z. T. (2011) · Diabetes Care · doi:10.2337/dc11-0007 · Cited by 32
Usefulness of Carotid Intima-Media Thickness in Patients With Diabetes Mellitus as a Predictor of Coronary Artery Disease
Djaberi, R., Schuijf, J. D., de Koning, E. J. P., Rabelink, T. J., Smit, J. W. A., Kroft, L. J. M., Pereira, A. M., Scholte, A. J. H. A., Spaans, M., Romijn, J. A., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.06.004 · Cited by 33
Implications of emerging risk factors for therapeutic intervention
Assmann, G., Cullen, P., Fruchart, J., Greten, H., Naruszewicz, M., OLSSON, A. G., Paoletti, R., Riesen, W., Stoll, M., Tikkanen, M. J., et al. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.06.011 · Cited by 33
Diabetes as a coronary artery disease risk equivalent: before a change of paradigm?
Saely, C. H., Aczél, S., Koch, L., Schmid, F. M., Marte, T., Huber, K., & Drexel, H. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32833100f0 · Cited by 32
¿La diabetes mellitus es un equivalente de riesgo coronario? Resultados de un metaanálisis de estudios prospectivos
González-Clemente, J. M., Palma, S., Arroyo, J., Vilardell, C., Caixàs, A., Giménez‐Palop, O., & Delgado‐Rodríguez, M. (2007) · Revista Española de Cardiología · doi:10.1157/13111789 · Cited by 32
Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
Palanca, A., Castelblanco, E., Betriu, À., Perpiñán, H., Soldevila, B., Valdivielso, J. M., Bermúdez-López, M., Puig-Jové, C., Puig‐Domingo, M., Groop, P., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0897-y · Cited by 32
Survival-related biases survive well
Saracci, R. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl263 · Cited by 32
Cerebrovascular disease in diabetes mellitus: The role of carotid intima-media thickness
de Kreutzenberg, S. V., Tiengo, A., & Avogaro, A. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.03.014 · Cited by 31
Stroke prevention in diabetes and obesity
Kurukulasuriya, L. R., Govindarajan, G., & Sowers, J. R. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.4.487 · Cited by 30
Cardiovascular effects of dipeptidyl peptidase-4 inhibitor in diabetic patients with and without established cardiovascular disease: a meta-analysis and systematic review
Xu, S., Zhang, X., Tang, L., Zhang, F., & Tong, N. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2017.1255537 · Cited by 30
Estimating Cardiovascular Risk in Spain Using Different Algorithms
Comín, E., Solanas, P., Cabezas, C., Subirana, I., Ramos, R., Badía, J. G., Cordón, F., Grau, M., Vila, J., & Marrugat, J. (2007) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60004-3 · Cited by 29
Cardioprotective effects of incretin during ischaemia-reperfusion
Chinda, K., Chattipakorn, S. C., & Chattipakorn, N. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112440816 · Cited by 28
Combination of ankle brachial index and diabetes mellitus to predict cardiovascular events and mortality after an acute coronary syndrome
Quiles, J., Morillas, P., Bertoméu, V., Mazón, P., Cordero, A., Soria, F., Fácila, L., & González‐Juanatey, J. R. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.04.097 · Cited by 28
Complications of Diabetes Mellitus
Brownlee, M., Aiello, L. P., Cooper, M. E., Vinik, A. I., Plutzky, J., & Boulton, A. J. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00033-2 · Cited by 29
Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism
Zhang, Z., Wang, J., Zhu, Y., Zhang, H., & Wang, H. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10716 · Cited by 28
Adiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus
Tonding, S. F., Silva, F. M., Antonio, J. P., de Azevedo, M. J., Canani, L. H. S., & de Almeida, J. C. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-124 · Cited by 27

Authors: Lee, C. D., Folsom, A. R., Pankow, J. S., & Brancati, F. L.
Affiliations: University of Minnesota (US)
ORCID: Folsom, Aaron R.
Pankow, James S.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-02-24
Volume: 109
Issue: 7
Pages: 855-860
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000116389.61864.de
OpenAlex: W2089154533
Cited by: 276
References: 40
Citations by year: 2026: 3 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 11 · 2020: 7 · 2019: 9 · 2018: 6 · 2017: 8 · 2016: 9 · 2015: 10 · 2014: 9 · 2013: 10 · 2012: 16
FWCI: 18.67
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hc55021-47-0-1, n01hc55020-39-0-0, n01hc55016-37-0-0, n01hc055022-024, n01hc55019-35-0-1, n01hc55018-38-0-1, n01hc55015-48-0-1)
National Heart, Lung, and Blood Institute (N01-HC55022, N01-HC-55018, N01 HC 55020, N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022, N01 HC 55019, N01-HC55016, N01‐HC‐55015, N01-HC55021, T32 HL07779, HL07779, T32HL007779)
National Institute of Diabetes and Digestive and Kidney Diseases (1K24 DK 6222-01, N01-HC-55016, N01-HC-55018, N01-HC-55021, N01-HC-55020, N01-HC-55015, N01-HC-55019, N01-HC-55022)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
Keywords: diabetes mellitus, myocardial infarction, coronary artery disease, stroke, cardiovascular mortality, cardiovascular risk, carotid intima-media thickness, African American adults, Atherosclerosis Risk in Communities Study
MeSH terms: Black or African American, Cardiovascular Diseases, Carotid Arteries, Diabetes Mellitus, Female, Follow-Up Studies, Humans, Hypercholesterolemia, Hypertension, Male, Middle Aged, Myocardial Infarction, Obesity, Risk, Smoking, Ultrasonography, United States, Cohort Studies, Comorbidity, Life Tables, Survival Analysis, Tunica Intima, Tunica Media, Stroke, White People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks